News and Updates

Explore the latest trends in U.S. healthcare spending, the impact of medical innovation, and the shift toward value-based care in this expert-led analysis.

Smaller biotech firms are entering the weight-loss market with oral pills, challenging industry giants as they push for easier, scalable obesity treatment.

TG Therapeutics has launched a Phase 2 trial for BRIUMVI to treat resistant schizophrenia, exploring the role of B-cell depletion in psychiatric care.

Hawaii opens its first early-phase cancer clinical trial center, giving patients local access to cutting-edge research and novel oncology therapies.

The FDA has authorized a new Parkinson’s disease clinical trial. Learn about this potential disease-modifying therapy and what it means for neuro research.

Can biomarkers predict depression treatment success? Discover how a new precision medicine trial using bupropion and sertraline is changing psychiatry.

A new clinical trial explores innovative treatments for heart failure, aiming to improve patient outcomes and reshape standard cardiac care protocols.

Explore the latest Phase III SENTRY trial results for selinexor. Discover how this XPO1 inhibitor is shaping the future of targeted oncology treatments.

Discover how AI is revolutionizing biologics manufacturing, optimizing bioprocessing, and accelerating drug development timelines in modern CDMO workflows.

EU regulators have reversed their approval recommendation for Tavneos (avacopan). Discover what this setback means for the ANCA-associated vasculitis drug.